Innovation in this space depends on strategizing for GMP compliance and market access.
Patrick Thiaville
Advertisement
Patrick Thiavilleis chief technology officer of Exothera.
Articles by Patrick Thiaville
Advertisement
Latest Updated Articles
Driving Innovation in Nucleic Acid TherapeuticsPublished: April 2nd 2024 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Everything to Know About Cell and Gene Therapy in 2025
2
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
3
CGT Innovations: The Three-Pronged Strategy for Industry Growth (Part 2)
4
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
5
